TRUNCATE-TB Clinical Trial

August 29, 2018 | 11:37 am

DLSMHSI Medical Research Center

The National University of Singapore is partnering with DLS HSI Research Division for the TRUNCATE-TB  trial.  TRUNCATE (Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for drug-sensitive Tuberculosis (TB)) is SPRINT-TB’s flagship clinical trial across multiple Asian countries evaluating the effectiveness of two-month treatment strategies for drug-sensitive TB. Funded by UK MRC/Wellcome Trust /DfID and Singapore NMRC, the trial includes treatment arms with novel combinations of established and new drugs that are currently in Phase 3 trials. The trial brings together a large team of clinicians, statisticians, microbiologists, and trial management staff across Asia and UK.

Trial team of the National University of Singapore and the DLSHSI TRUNCATE trial team during the site initiation visit


TB Fit Project

August 29, 2018 | 11:45 am